Delivery Order SPE2DB20D1100-SPE2DB25FD3N4
Award Date
7/10/25
Potential Completion Date
7/11/25
Potential Value
$10K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,257.04, is for the delivery of the pharmaceutical product "KONVOMEP 2-84 MG/ML ORAL SUSP 300ML" and has a completion date of April 15, 2025. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,616.87 Firm Fixed Price Delivery Order is for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of October 6, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $1,399.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of KONVOMEP 2-84 MG/ML ORAL SUSP 90ML, a pharmaceutical product, under a Firm Fixed Price contract type. The contract has an ultimate completion date of May 2, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,042.18, is a Firm Fixed Price Delivery Order to provide KONVOMEP 2-84 MG/ML ORAL SUSP 90ML, a pharmaceutical product. The award has an ultimate completion date of December 10, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor and holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, a pharmaceutical product, with a ceiling value of $4,091.91 and a performance period through May 8, 2025. The contract is a delivery order, with a firm fixed price pricing type. It is not set aside for any specific business category....
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $1,071.00 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply KONVOMEP 2-84 MG/ML oral suspension (90 ml). This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which enables the government to efficiently procure a comprehensive range of medical commodities to support military...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order (contract #SPE2DB20D1047|SPE2DB24FF60Z) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4564232214 KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, a pharmaceutical product. The award, with a ceiling value of $5,772.01, has an ultimate completion date of April 11, 2024. This delivery order is issued under an indefinite delivery contract (IDC) valued at up to $999,999,999.00 through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract is for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, a pharmaceutical product. The delivery order is for $4,743.00 and has a performance period through May 24, 2023. This award does not have a set-aside designation, indicating full and open competition....
This federal contract award, valued at $1,903.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, designated as SPE2DB20D1100|SPE2DB25FB9B5, is a delivery order contract for the supply of the pharmaceutical product "KONVOMEP 2-84 MG/ML ORAL SUSP 300ML". The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product KONVOMEP 2-84 MG/ML ORAL SUSP 150ML. The contract, valued at $2,532.72, is a firm fixed-price delivery order with an ultimate completion date of August 1, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is the prime contractor for this award. This delivery order is part of a...